Green Cross Health Ltd · NZX:GXH
Green Cross Health — FY2023 Earnings Presentation
27 slides from Green Cross Health's earnings presentation, May 30, 2023
Slide 1: Green Cross Health Annual Results
GREEN CROSS HEALTH Annual Results for the Unichem? Life-© @pinrop GREEN - thedoctors House HEALTH
Slide 2: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability
Slide 3: Operational Highlights
Operational Highlights • $15.5m increase in Group Revenue year-on-year Group • 89% increase in reported Net Profit After Tax attributable to shareholders1 • Divestment of Community Health division on 28 February Highlights 2023, gain of $21.8m • GXH recognised as a Top 10 most desirable place to wor
Slide 4: Community Health Division Divested
Community Health Division Divested • In February 2023, Access Community Health and Total Care Health were divested to Anchorage Capital Partners • The sale valued the Community Health Division at an enterprise value of $50.0m • Gain on sale of $21.8m • Net cash sale proceeds supported the payment of
Slide 5: GXH Annual Result - Financial Overview
GXH Annual Result - Financial Overview Group Performance Divisional Performance Group Revenue (continuing operations) Pharmacy Operating Profit $493.6m $21.1m 3% increase vs FY22 41% decrease vs FY22 Operating Profit/EBIT (continuing operations) Medical Operating Profit $34.3m $16.2m 29% decrease vs
Slide 6: Pharmacy Division
Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care
Slide 7: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue ($m) 367.1 360.4 • Revenue of $360.4m 336.4 316.8 • Operating Profit at $21.1m FY20 FY21 FY22 FY23 • Following record profit in FY22 driven by COVID-19 vaccination activity, Pharmacy Operating Profit ($m) Operating Profit down 41% with shift in revenue
Slide 8: Record Year For Flu Vaccinations
Record Year For Flu Vaccinations 300 285 250 200 175 Thousands 148 150 140 114 100 91 91 74 50 110 49 57 40 0 FY20 FY21 FY22 FY23 GXH Equity pharmacies GXH Licensee pharmacies • COVID-19 vaccination resource diverted to focus on flu vaccinations, with volumes up 93% year on year GXH Annual Results P
Slide 9: Living Rewards Members Spend 65% More Than Non-members
Living Rewards Members Spend 65% More Than Non-members Continued Growth in Living Rewards Members 1,952,661 Living 2.00 1.95 Rewards Members 1.90 Million members 1.85 ✓ 3.5% growth in Living Rewards members to 1.95m 1.80 1.75 ✓ Successful new member acquisition campaigns 1.70 1.65 added 66,583 new m
Slide 10: Differentiated Products Increased to 23% of Retail Sales
Differentiated Products Increased to 23% of Retail Sales Growth in Differentiated Brand Sales Average E-commerce Order Value Lifted 25% $100 Average order value % of Retail sales 7% 6% 20% $80 Average order value % of retail sales 5% % of retail sales 15% $60 4% 10% $40 3% 2% 5% $20 1% 0% $0 0% FY20
Slide 11: Investment in Technology and People
Investment in Technology and People Technology • Digital capability enhanced through partnership with technology company MedAdvisor • 223 stores now using SMS alerts, reaching almost 500,000 customers • Unichem and Life Pharmacy branded app to support omni-channel customer interaction built and laun
Slide 12: Largest National Pharmacy Network
Largest National Pharmacy Network 285 ✓ New Zealand’s largest network of health retailers with 342 stores nationwide ✓ Dispensed over 34 million scripts, representing ~40% of all New Zealand volumes 57 ✓ Year-on-year growth in GXH equity store script volumes, with initial script volumes up 11% and t
Slide 13: Pharmacy Will Win By Focusing on the Customer
Pharmacy Will Win By Focusing on the Customer Workforce productivity Differentiated brand and & occupancy cost products, recognising control Brand & customer loyalty Cost focus customer Leveraging our trusted Professional instore brands, advocating for equity Network scale & Retail experience, margi
Slide 14: Medical Division
Medical Division Growth, leadership and sustainable models of care
Slide 15: Medical Performance
Medical Performance Medical Operating Revenue ($m) 133.2 111.0 Revenue up 20% to $133.2m, driven 76.5 82.2 by COVID-19 activity in the first half of the year, along with acquisitions Operating Profit up 1% to $16.2m, FY20 FY21 FY22 FY23 with labour cost pressures and reduced COVID-19 swabbing Medica
Slide 16: Acquiring and Integrating New Centres
Acquiring and Integrating New Centres ✓ Another year of accelerated Medical Acquisitions acquisition activity with eight centres acquired in year, to close 9 8 with 61 medical centres ✓ Two more acquisitions completed post year-end 3 1 ✓ Strong pipeline of future FY20 FY21 FY22 FY23 acquisitions ✓ T
Slide 17: Growing The Doctors Brand
Growing The Doctors Brand The Doctors rebrand programme continues with five centres completed in year Upgrades to modernise three medical centres, improving operational efficiencies and enhancing the patient experience Refurbishments 3 3 1 0 FY20 FY21 FY22 FY23 GXH Annual Results Presentation 30 May
Slide 18: Operational Improvement Initiatives Continue
Operational Improvement Initiatives Continue Double Digit EBIT Margin Through Operational Efficiency and Cost Management 80% 16% ✓ Following record-high COVID-19 earnings in 70% 14% FY22, EBIT margin came in at 12% for 60% 12% FY23, despite inflationary labour pressures ✓ Other costs reduced to ~17%
Slide 19: Focus on Technology
Focus on Technology Further investment in newly created Virtual Care Team and expansion of HouseCall digital consultation capability No. of SMS texts No. of website sent 3,072,671 hits 520,038 Page views Patient emails sent via 1,300,206 Chatterbox 411,466 GXH Annual Results Presentation 30 May 2023
Slide 20: Medical Strategy of Organic Growth & Acquisitions
Medical Strategy of Organic Growth & Acquisitions Workforce productivity High quality patient care & margin management Cost & margin Patient & focus Brand Continuous improvement Targeted centre focus, clinical development acquisitions Operational Scale improvement Technology Utilising data and syste
Slide 21: Group Financial Result
Group Financial Result 12 months ending 31 March 2023 GXH Annual Results Presentation 30 May 2023 Pg 21
Slide 22: Group Revenue and Operating Profit
Group Revenue and Operating Profit GXH Operating Revenue From Continuing Operations GXH Operating Profit From Continuing Operations ($m) ($m) 48.5 478 494 34.3 413 399 29.8 31.4 FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 • Revenue of $494m, up 3% • Operating Profit from continuing operations of • FY23
Slide 23: Group NPAT, EPS & Dividend
Group NPAT, EPS & Dividend GXH Net Profit After Tax Attributable to Shareholders Dividends Per Share ($m) (cps) 45.2 6.5 7.0 23.9 16.8 3.5 13.5 0.0 FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 Based on dividends declared during the financial year GXH Net Profit After Tax Attributable to Shareholders (cps
Slide 24: Working Capital Management Disciplines Supporting Further Acquisition Activity
Working Capital Management Disciplines Supporting Further Acquisition Activity Gearing Ratio (debt / debt + equity attributable to GXH Operating Cash Flow ($m) shareholders) 29.5% 70.9 65.8 54.3 45.9 14.0% 13.3% 11.0% FY20 FY21 FY22 FY23 FY20 FY21 FY22 FY23 • Gearing ratio of 11.0% in FY23 • Operati
Slide 25: About Green Cross Health
About Green Cross Health GXH Annual Results Presentation 25 May 27 June2022 2020 Pg 25Pg 25
Slide 26: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Annual Results Presentation 25 May 27 June2022 2020 Pg 26Pg 26
Slide 27: Who We Are
Who We Are Pharmacies providing extensive range of health, wellness and beauty related products and services across communities throughout New Zealand, supported by digital offerings General practice networks across New Zealand, offering in-practice and virtual services GXHAs at May Annual 2023 Pres